At the 2017 ISPOR European Congress, a workshop was organised where representatives from the National Institute for Health and Care Excellence (NICE), the University of Sheffield, the Office of Health Economics (OHE), London and the EuroQol Research Foundation jointly presented on the differences between the EQ-5D-3L and EQ-5D-5L value sets for the UK. Dr. Rosemary Lovett, Senior Scientific Advisor at NICE, indicated that NICE continues to support the use of the EQ-5D-5L descriptive system in clinical studies. Furthermore, she indicated that NICE is keen to update methods to reflect current best practice but will maintain current methods guide whilst commissioning and supporting further research regarding the differences between the EQ-5D-3L and EQ-5D-5L instruments and the currently available value sets. She referred to the NICE position statement which recommends that the EQ-5D-3L value set should be used for reference case analyses. If data were gathered using the EQ-5D-5L descriptive system, the mapping function developed by van Hout et al. (2012) should be used to derive utility values from the current UK 3L value set. NICE plans to review this policy in the summer of 2018.
Dr. Rosemary Lovett, Dr. Allan Wailoo (Sheffield), and Dr. Nancy Devlin (OHE), representing the EuroQol Research Foundation, gave presentations, with Dr. John Brazier (Sheffield) moderating the workshop. For more information, please click on presentations available under W10 : EQ-5D: IS NICE READY FOR THE NEXT LEVEL? via the following link.